title: Primary debulking surgery for advanced ovarian cancer: are you a believer or a dissenter?
abstract: Nothing stirs the collective soul of primary debulking surgery (PDS) advocates like hard data suggesting equivalent outcomes of neoadjuvant chemotherapy (NAC). These opposing views have even metaphorically come to blows at the highly entertaining "SGO Fight Night" that took place during the 2008 Annual Meeting on Women's Cancer, replete with teams supporting each of the would-be gladiators. Decades of retrospective data supporting the clinical benefit of PDS has recently been challenged by the publication in 2010 of a randomized phase III trial conducted in Europe supporting the clinical efficacy of NAC. Naturally, a firestorm of criticism among believers ensued, yet practice patterns within the United States did slowly change, suggesting an emerging block of dissenters. Another randomized phase III European trial, as presented in abstract form in 2013, showed similar findings. Few other topics within the field of gynecologic oncology have participants so entrenched in the "corners" of their existing practice patterns. This review attempts to consolidate the current evidence supporting both sides so that the patient can be declared the winner.
authors.affiliation: Vincent Gynecologic Oncology Service, Massachusetts General Hospital, USA. Electronic address: jschorge@partners.org.
authors.forename: John O
authors.initials: JO
authors.lastname: Schorge
authors.affiliation: Vincent Gynecologic Oncology Service, Massachusetts General Hospital, USA.
authors.forename: Rachel M
authors.initials: RM
authors.lastname: Clark
authors.affiliation: Division of Abdominal Imaging, Massachusetts General Hospital, USA.
authors.forename: Susanna I
authors.initials: SI
authors.lastname: Lee
authors.affiliation: Division of Medical Gynecologic Oncology, Gillette Center for Gynecologic Oncology, Massachusetts General Hospital, USA.
authors.forename: Richard T
authors.initials: RT
authors.lastname: Penson
mesh_terms: D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000601:surgery*
keywords: Advanced ovarian cancer; Neoadjuvant chemotherapy; Primary debulking surgery